Entity

Time filter

Source Type

Plouzane, France

The Institut français de recherche pour l'exploitation de la mer is an oceanographic institution in France. Wikipedia.


Patent
French Research Institute for Exploitation of the Sea and University of Paris Descartes | Date: 2015-08-10

The invention relates to certain low-molecular weight sulphated polysaccharide derivatives of marine native exopolysaccharides (EPSs) excreted by mesophilic marine bacteria from a deep hydrothermal environment, wherein said derivatives can be obtained by means of a method which comprises a step of free radical depolymerisation of said native EPSs followed by a step of sulphating the resulting depolymerised derivatives. The present invention further relates to the use of said low-molecular weight sulphated polysaccharide derivatives as a wound-healing agent, particularly for preparing pharmaceutical compositions suitable for treating or preventing diseases of the connective tissues and particularly skin and gum tissues. The figure demonstrates how polysaccharide derivative GY 785 DRS according to the invention can stimulate fibroblast proliferation in latticed or reconstructed connective tissues at a concentration of 10 g (m) g/ml.


Patent
French Research Institute for Exploitation of the Sea and University of Paris Descartes | Date: 2011-01-07

The invention relates to certain low-molecular weight sulphated polysaccharide derivatives of marine native exopolysaccharides (EPSs) excreted by mesophilic marine bacteria from a deep hydrothermal environment, wherein said derivatives can be obtained by means of a method which comprises a step of free radical depolymerisation of said native EPSs followed by a step of sulphating the resulting depolymerised derivatives. The present invention further relates to the use of said low-molecular weight sulphated polysaccharide derivatives as a wound-healing agent, particularly for preparing pharmaceutical compositions suitable for treating or preventing diseases of the connective tissues and particularly skin and gum tissues. The figure demonstrates how polysaccharide derivative GY 785 DRS according to the invention can stimulate fibroblast proliferation in latticed or reconstructed connective tissues at a concentration of 10 g (m) g/ml.


Patent
French Research Institute for Exploitation of the Sea | Date: 2012-08-16

A novel microalgal strain whose lipid production has been enhanced compared to the wild type. The lipid content produced by the microalgae is particularly rich in neutral lipids. The use of the microalgal strain and the lipids are also described.


Patent
French Research Institute for Exploitation of the Sea | Date: 2011-05-05

A system for measuring or monitoring the quality of a liquid medium, has first and second sample-takeoff points in the liquid medium and a hydraulic circuit in which the samples taken off from said first and second sample-takeoff points circulate. The hydraulic circuit is mounted between the two sample-takeoff points and comprises two centrifugal impeller pumps, a measuring chamber situated between the two pumps, and a purge device mounted at a high point on the hydraulic circuit between one of the pumps and the measuring chamber. The whole of the hydraulic circuit is preferably totally immersed in the liquid medium.


Patent
University of Paris Descartes and French Research Institute for Exploitation of the Sea | Date: 2013-10-11

The invention relates to certain low-molecular weight sulphated polysaccharide derivatives of marine native exopolysaccharides (EPSs) excreted by mesophilic marine bacteria from a deep hydrothermal environment, wherein said derivatives can be obtained by means of a method which comprises a step of free radical depolymerisation of said native EPSs followed by a step of sulphating the resulting depolymerised derivatives. The present invention further relates to the use of said low-molecular weight sulphated polysaccharide derivatives as a wound-healing agent, particularly for preparing pharmaceutical compositions suitable for treating or preventing diseases of the connective tissues and particularly skin and gum tissues. The figure demonstrates how polysaccharide derivative GY 785 DRS according to the invention can stimulate fibroblast proliferation in latticed or reconstructed connective tissues at a concentration of 10 g (m) g/ml.

Discover hidden collaborations